These new trials (FLOW [29], SOUL [49], SELECT[68]) will be informative about additional patient groups that may benefit from GLP1-RA for kidney and heart protection
Hecht J, Kopetz S , Patel SP, Welling T, Morelli MP, Borad MJ, Molina JR, Kirtane K, Lin Y, Fan-Port M, Mardiros A, Beutner K, Lozac'hmeur A, Lau D, Liechty KB, Vong J, Ng E, Maloney DG, Go WY, Simeone DM
Mezquita Raya, M
It says early administration is not appropriate as a regular pattern or as a workaround, and warns that repeatedly shifting the schedule forward can produce cumulative changes in medication levels and unpredictable side effects
2, 2015, doi:10.5041/rmmj.10204
For many people who have spent years struggling with their weight despite rigorous dieting and exercise, these medications offer a new sense of hope